Health Law Asia provides specialized legal and regulatory consultancy for companies operating in highly regulated industries across China and the Far East.
Our multilingual legal team supports pharmaceutical, medical device, cosmetics, and healthcare organizations in achieving compliance, managing risk, and developing sustainable business strategies throughout Asia.
The pharmaceutical markets in China and the Far East are among the most dynamic and complex in the world, shaped by innovation, evolving regulation, and growing cross-border activity.
Health Law Asia offers tailored legal consultancy services that help pharmaceutical companies navigate this challenging environment with confidence.
With deep knowledge of China’s National Medical Products Administration (NMPA) framework, cross-border drug approvals, data protection, and foreign investment policies, our legal experts deliver clear, actionable guidance aligned with each client’s strategic goals.
We support clients at every stage of the pharmaceutical lifecycle — from clinical trials and IP strategy to market access, licensing, and compliance — across China, South Korea, Japan, Singapore, Vietnam, Thailand, and other Southeast Asian markets.
Practical cases include:
Operating in the medical device industry in China and the Far East demands precision, agility, and a deep understanding of local frameworks.
Health Law Asia provides dedicated legal and regulatory support to medical device companies seeking to operate, expand, or comply in these fast-evolving markets.
Our team advises on product classification, clinical evaluation filings, quality system compliance, distributor agreements, and post-market obligations.
We help clients align with China NMPA, and other Asian Countries regulatory Agencies (Japan PMDA etc), and ASEAN harmonization requirements, bridging global standards with local practice.
Practical cases include:
The cosmetics industry in China and Asia offers major growth potential but operates under strict regulatory control.
Health Law Asia provides expert legal advice on compliance with the Cosmetics Supervision and Administration Regulation (CSAR) and similar frameworks in Korea, Japan, and other ASEAN countries.
We assist clients with product registration, ingredient review, labeling, cross-border e-commerce, and IP protection.
Our team also advises on animal testing exemptions, licensing, and risk management when dealing with authorities such as, among others, China’s NMPA and Korea’s MFDS.
Practical cases include:
Beyond product compliance, success in Asia requires robust corporate structures and legal strategies.
Health Law Asia supports clients with corporate setup, joint ventures, M&A, foreign investment, labor law, data protection, and commercial contracts, ensuring compliance across China, Japan, Korea, and Southeast Asia.
Our integrated approach combines regulatory expertise with corporate law to help companies grow sustainably and protect their business interests in highly regulated sectors.
Practical cases include:
Health Law Asia provides strategic legal advisory services for public and private healthcare institutions — including hospitals, research centers, and universities — aiming to build partnerships in China and the ASEAN region.
We advise on MOUs, PPP models, joint research, academic collaborations, and clinical trial partnerships, ensuring compliance with local regulations and governance standards.
Our multidisciplinary team helps clients manage legal, contractual, and compliance aspects in cooperation with government agencies, hospitals, and universities throughout Asia.
Practical cases include: